EUVIMEDEUVIMED entdecken
Crossref

Thyroid Hormone Treatment for Hypercholesterolemia in Euthyroid Patients: Results From a European Survey of Thyroid Specialists

Juan C Galofré iD, Juan J Díez iD, Roberto Attanasio iD, Endre V Nagy iD, Tomasz Bednarczuk iD, Enrico Papini iD, Miloš Žarković iD, Roberto Negro iD, Petros Perros iD, Ersin Akarsu iD, Maria Alevizaki iD, Göksun Ayvaz iD und 36 weitere

Clinical Endocrinology · 2025

DOI: 10.1111/cen.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Juan C Galofré und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Hypercholesterolemia, Thyroid Hormones, Hypothyroidism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A relationship among hypothyroidism and lipid disorders is well established. However, current evidence and guidelines do not support the use of thyroid hormones (TH) in euthyroid patients with hyperlipidaemia as potential harms are considerable. This European survey investigated the use of TH in euthyroid patients with severe hypercholesterolemia as a complementary treatment.

Design

Data were derived from the THESIS (Treatment of Hypothyroidism in Europe by Specialists) project that surveyed TH use. Univariable and multivariable analyses were used to explore associations.

Results

Out of 17,232 invitations, 5695 (33.0%) valid responses were received, and of these, 328 (5.8%) stated that TH are indicated in euthyroid patients with severe hypercholesterolemia. Univariable analyses disclosed significant differences and associations: (a) more non‐endocrinologists (8.9%) than endocrinologist (5.4%) used TH ( p < 0.001), (b) the number of hypothyroid patients treated per year was inversely related to use of TH ( p = 0.024), (c) members of international endocrine/thyroid societies were more likely to use TH than non‐members ( p < 0.001), (d) significant variations by country and geographical region ( p < 0.001), and (e) inverse relationship between gross national income per capita (GNIPC) and TH use ( p < 0.001). Multivariable analyses yielded significant associations between use of TH, and male gender, specialty and GNIPC ( p < 0.001).

Conclusions

This study suggests that a small but noteworthy minority of European thyroid specialists may be using TH to treat of severe hypercholesterolemia in euthyroid patients. If confirmed, this finding highlights the importance of raising awareness among thyroid specialists, professional societies, and healthcare providers to ensure adherence to evidence‐based practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaThyroid HormonesHypothyroidismHumansFemaleMaleEuropeMiddle AgedSurveys and QuestionnairesAdultEndocrinologistsPractice Patterns, Physicians'

Stichwörter der Autor:innen

euthyroidismhypercholesterolemialevothyroxinemisusetreatment

Substanzen

Thyroid Hormones

Autor:innen und Institutionen

  • Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Thyroid Task Force from the Sociedad Española de Endocrinología y Nutrición (SEEN), Pamplona, Spain.
  • Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
  • Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Madrid, Spain.
  • Department of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.

ORCID-Profile: Juan C Galofré, Juan J Díez, Roberto Attanasio, Endre V Nagy, Tomasz Bednarczuk, Enrico Papini, Miloš Žarković, Roberto Negro, Petros Perros, Ersin Akarsu, Maria Alevizaki, Göksun Ayvaz, Eszter Berta, Biljana Nedeljković Beleslin, Miklos Bodor, Anna Maria Borissova, Mihail Boyanov, Maria-Cristina Burlacu, Jasmina Ćirić, Valentin Fadeyev, Benjamin C T Field, Dagmar Führer, Jiskra Jan, Peter Kopp, Michael Krebs, Michal Kršek, Ivica Lazúrová, Vitaliy Luchytskiy, Anne McGowan, Miguel Melo, Saara Metso, Carla Moran, Tatyana Morgunova, Dan Alexandru Niculescu, Božidar Perić, Tereza Planck, Eyal Robenshtok, Patrick Olivier Rosselet, Marek Ruchala, Alla Shepelkevich, Mykola Tronko, David Unuane, Irfan Vardarli, W Edward Visser, Andromachi Vryonidou, Younes R Younes, Laszlo Hegedüs

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Galofré, J. C., Díez, J. J., Attanasio, R., Nagy, E. V., Bednarczuk, T., Papini, E., Žarković, M., Negro, R., Perros, P., Akarsu, E., Alevizaki, M., Ayvaz, G., Berta, E., Beleslin, B. N., Bodor, M., Borissova, A. M., Boyanov, M., Burlacu, M. C., Ćirić, J., …, & Hegedüs, L. (2025). Thyroid Hormone Treatment for Hypercholesterolemia in Euthyroid Patients: Results From a European Survey of Thyroid Specialists. Clinical Endocrinology. https://doi.org/10.1111/cen.70014

Vancouver

Galofré JC, Díez JJ, Attanasio R, Nagy EV, Bednarczuk T, Papini E, et al. Thyroid Hormone Treatment for Hypercholesterolemia in Euthyroid Patients: Results From a European Survey of Thyroid Specialists. Clinical Endocrinology. 2025. doi:10.1111/cen.70014

BibTeX
@article{Galofr2025,
  author = {Galofré, Juan C and Díez, Juan J and Attanasio, Roberto and Nagy, Endre V and Bednarczuk, Tomasz and Papini, Enrico and Žarković, Miloš and Negro, Roberto and Perros, Petros and Akarsu, Ersin and Alevizaki, Maria and Ayvaz, Göksun and Berta, Eszter and Beleslin, Biljana Nedeljković and Bodor, Miklos and Borissova, Anna Maria and Boyanov, Mihail and Burlacu, Maria-Cristina and Ćirić, Jasmina and Fadeyev, Valentin and Field, Benjamin C T and Führer, Dagmar and Jan, Jiskra and Kopp, Peter and Krebs, Michael and Kršek, Michal and Lazúrová, Ivica and Luchytskiy, Vitaliy and Puga, Francisca Marques and McGowan, Anne and Miguel Melo and Metso, Saara and Moran, Carla and Morgunova, Tatyana and Niculescu, Dan Alexandru and Perić, Božidar and Planck, Tereza and Robenshtok, Eyal and Rosselet, Patrick Olivier and Ruchala, Marek and Shepelkevich, Alla and Tronko, Mykola and Unuane, David and Vardarli, Irfan and Visser, W Edward and Vryonidou, Andromachi and Younes, Younes R and Hegedüs, Laszlo},
  title = {Thyroid Hormone Treatment for Hypercholesterolemia in Euthyroid Patients: Results From a European Survey of Thyroid Specialists},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.70014}
}
Kostenlos starten →